Progress in the development of a cervical cancer vaccine.

about

Recombinant measles virus-HPV vaccine candidates for prevention of cervical carcinoma.

P2860

Q36366466-641E6481-5B1B-41C9-96F4-AE14A9136EC6

P2860

Progress in the development of a cervical cancer vaccine.

Item

http://www.wikidata.org/entity/Q35919119

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

2006年论文

@zh

2006年论文

@zh-cn

name

Progress in the development of a cervical cancer vaccine.

@ast

Progress in the development of a cervical cancer vaccine.

@en

type

Item

label

Progress in the development of a cervical cancer vaccine.

@ast

Progress in the development of a cervical cancer vaccine.

@en

prefLabel

Progress in the development of a cervical cancer vaccine.

@ast

Progress in the development of a cervical cancer vaccine.

@en

P1476

Progress in the development of a cervical cancer vaccine

@en

P2093

Henry Kitchener

http://www.w3.org/2001/XMLSchema#string

Richard Roden

http://www.w3.org/2001/XMLSchema#string

Ursula Winters

http://www.w3.org/2001/XMLSchema#string

P2860

Global cancer statistics, 2002

The papillomavirus life cycle

Therapeutic vaccination with MVA E2 can eliminate precancerous lesions (CIN 1, CIN 2, and CIN 3) associated with infection by oncogenic human papillomavirus

Against which human papillomavirus types shall we vaccinate and screen? The international perspective

Human papillomavirus is a necessary cause of invasive cervical cancer worldwide

The influenza vaccine licensing process.

Systemic immunization with papillomavirus L1 protein completely prevents the development of viral mucosal papillomas.

Large loop excision of the transformation zone (LLETZ). A new method of management for women with cervical intraepithelial neoplasia.

Management of women who test positive for high-risk types of human papillomavirus: the HART study.

Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group.

P304

259-269

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/TCRM.2006.2.3.259

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Peter Stern

P577

2006-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5490998

http://www.w3.org/2001/XMLSchema#string

P698

18360601

http://www.w3.org/2001/XMLSchema#string

P932

1936262

http://www.w3.org/2001/XMLSchema#string

Progress in the development of a cervical cancer vaccine.

about

P2860

P2860

Progress in the development of a cervical cancer vaccine.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P932